Reuters logo
BRIEF-Cue Biopharma announces collaboration with Merck
November 16, 2017 / 1:29 PM / a month ago

BRIEF-Cue Biopharma announces collaboration with Merck

Nov 16 (Reuters) - Cue Biopharma

* ‍Cue Biopharma says a strategic research collaboration and license agreement with Merck

* Cue Biologics platform will be leveraged to develop biologics engineered to selectively modulate disease-relevant T cell subsets​

* Says specific financial arrangements are not being disclosed​

* Says will receive an up-front payment​

* Eligible to earn up to $374 million in research, regulatory & commercial milestone payments in addition to tiered royalties on sales​ Source text for Eikon: Further company coverage: [Cue Biopharma]

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below